# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600620-26-000049
Filing Date
2026-05-07
Accepted
2026-05-07 08:23:35
Documents
68
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | auph-20260331.htm iXBRL | 10-Q | 759259
2 | EX-3.3 | exhibit33.htm | EX-3.3 | 90137
3 | EX-3.4 | exhibit34.htm | EX-3.4 | 91556
4 | EX-3.5 | exhibit35.htm | EX-3.5 | 100227
5 | EX-3.6 | exhibit36.htm | EX-3.6 | 94690
6 | EX-3.7 | exhibit37amendedandrestate.htm | EX-3.7 | 113202
7 | EX-31.1 | auph-2026q1exx311.htm | EX-31.1 | 10761
8 | EX-31.2 | auph-2026q1exx312.htm | EX-31.2 | 10916
9 | EX-32.1 | auph-2026q1exx321.htm | EX-32.1 | 5239
10 | EX-32.2 | auph-2026q1exx322.htm | EX-32.2 | 5266
16 |  | auphlogoregistered.jpg | GRAPHIC | 17097
17 |  | auphlogoregistered1.jpg | GRAPHIC | 17097
18 |  | auphlogoregistered2.jpg | GRAPHIC | 17097
19 |  | auphlogoregistered3.jpg | GRAPHIC | 17097
| Complete submission text file | 0001600620-26-000049.txt |  | 5560928

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | auph-20260331.xsd | EX-101.SCH | 29416
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | auph-20260331_cal.xml | EX-101.CAL | 70044
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | auph-20260331_def.xml | EX-101.DEF | 136850
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | auph-20260331_lab.xml | EX-101.LAB | 516795
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | auph-20260331_pre.xml | EX-101.PRE | 336572
72 | EXTRACTED XBRL INSTANCE DOCUMENT | auph-20260331_htm.xml | XML | 579627

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 26951017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)